The Role of Arrestins in Visual and Disease Processes of the Eye - Progress in Molecular Biology and Translational Science - page 256

93. Whiteheart SW, Rossnagel K, Buhrow SA, Brunner M, Jaenicke R, Rothman JE.
N-ethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of
ATP is required for membrane fusion. J Cell Biol . 1994;126:945 - 954.
94. Brown BM, Ramirez T, Rife L, Craft CM. Visual arrestin 1 contributes to cone pho-
toreceptor survival and light-adaptation. Invest Ophthalmol Vis Sci . 2010;51:2372 - 2380.
95. Huang SP, Craft CM. Potential cellular functions of N-ethylmaleimide sensitive factor
in the photoreceptor. Adv Exp Med Biol . 2012;723:791 - 797.
96. McDonald PH, Cote NL, Lin FT, Premont RT, Pitcher JA, Lefkowitz RJ. Identifi-
cation of NSF as a beta-arrestin1-binding protein—implications for beta(2)-adrenergic
receptor regulation. J Biol Chem . 1999;274:10677 - 10680.
97. Okawa H, Sampath AP, Laughlin SB, Fain GL. ATP consumption by mammalian rod
photoreceptors in darkness and in light. Curr Biol . 2008;18:1917 - 1921.
98. Winkler BS, Starnes CA, Twardy BS, Brault D, Taylor RC. Nuclear magnetic reso-
nance and biochemical measurements of glucose utilization in the cone-dominant gro-
und squirrel retina. Invest Ophthalmol Vis Sci . 2008;49:4613 - 4619.
99. Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, Gal A. A homozygous 1-base
pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat
Genet . 1995;10:360 - 362.
100. Yoshii M, Murakami A, Akeo K, et al. Visual function and gene analysis in a family with
Oguchi's disease. Ophthalmic Res . 1998;30:394 - 401.
101. Fujinami K, Tsunoda K, Nakamura M, Oguchi Y, Miyake Y. Oguchi disease with
unusual findings associated with a heterozygous mutation in the SAG gene. Arch
Ophthalmol . 2011;129:1375 - 1376.
102. Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms
of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am
J Ophthalmol . 2000;130:547 - 563.
103. Hashimoto H, Kishi S. Shortening of the rod outer segment in Oguchi disease. Graefes
Arch Clin Exp Ophthalmol . 2009;247:1561 - 1563.
104. Hayashi T, Tsuzuranuki S, Kozaki K, Urashima M, Tsuneoka H. Macular dysfunction
in Oguchi disease with the frequent mutation 1147delA in the SAG gene. Ophthalmic
Res . 2011;46:175 - 180.
105. Chen J, Simon MI, Matthes MT, Yasumura D, LaVail MM. Increased susceptibility to
light damage in an arrestin knockout mouse model of Oguchi disease (stationary night
blindness). Invest Ophthalmol Vis Sci . 1999;40:2978 - 2982.
106. Sommer ME, Farrens DL. Arrestin can act as a regulator of rhodopsin photochemistry.
Vision Res . 2006;46:4532 - 4546.
107. Nakamachi Y, Nakamura M, Fujii S, Yamamoto M, Okubo K. Oguchi disease with
sectoral retinitis pigmentosa harboring adenine deletion at position 1147 in the arrestin
gene. Am J Ophthalmol . 1998;125:249- 251.
108. Nakazawa M, Wada Y, Tamai M. Arrestin gene mutations in autosomal recessive ret-
initis pigmentosa. Arch Ophthalmol . 1998;116:498 - 501.
109. Isashiki Y, Ohba N, Kimura K, Sonoda S, Kakiuchi T, Ozawa T. Retinitis pigmentosa
with visual fluctuations and arrestin gene mutation. Br J Ophthalmol . 1999;83:

1197- 1198.
110. Alloway PG, Howard L, Dolph PJ. The formation of stable rhodopsin-arrestin com-
plexes induces apoptosis and photoreceptor cell degeneration. Neuron . 2000;28:
129 - 138.
111. Iakhine R, Chorna-Ornan I, Zars T, et al. Novel dominant rhodopsin mutation trig-
gers two mechanisms of retinal degeneration and photoreceptor desensitization.
J Neurosci . 2004;24:2516 - 2526.